VANCOUVER, British Columbia, May 21, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical stage pharmaceutical company discovering and developing targeted therapeutics for inflammatory disease and cancer, today announced that David Main, Aquinox's Chief Executive Officer, will present at two upcoming investor conferences.
| Jefferies 2014 Global Healthcare Conference |
| Monday, June 2, 2014, at 3:00 P.M. Eastern Time |
| Grand Hyatt Hotel in New York, NY |
| A live audio webcast and archive of the event will be available at: http://wsw.com/webcast/jeff82/AQXP |
| 2014 Bloom Burton & Co. Healthcare Investor Conference |
| Wednesday, June 18, 2014, at 9:30 A.M. Eastern Time |
| Toronto Board of Trade in Toronto, Canada |
The corporate overview being presented at both conferences will be available at http://aqxpharma.com/content/corporate-presentation.
About Aquinox Pharmaceuticals
Aquinox Pharmaceuticals, Inc. is a clinical stage pharmaceutical company discovering and developing novel, small molecule therapeutics targeting SH2-containing inositol-5'-phosphatase 1 ("SHIP1") for the treatment of inflammatory disease and cancer. For more information please visit www.aqxpharma.com.